Entera Bio Ltd — Quarterly Financial Statistics (NASDAQ:ENTX) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 2.15 M1.47 M1.4 M1.63 M2.5 M 7 M Cash from investing activities 03 0008 00029 K43 K 83 K Cash from financing activities 13 K3.22 M13.34 M-51 K250 K 16.75 M Free cash flow 2.15 M1.46 M1.4 M1.6 M2.46 M 6.92 M

ニュース

What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours - Entera Bio (NASDAQ:ENTX)

Opko Health: rating "Buy" confermato da H.C. Wainwright

Opko Health stock rating reiterated at Buy by H.C. Wainwright

Entera Bio nomina Geno Germano presidente del consiglio di amministrazione

Entera Bio appoints Geno Germano as board chairman

OPKO and Entera expand collaboration to develop oral PTH treatment

Entera Bio pianifica la presentazione alla FDA del farmaco per l’osteoporosi nel Q1 2026

Entera Bio plans FDA submission for osteoporosis drug in Q1 2026

H.C. Wainwright conferma rating Buy su Entera Bio dopo qualifica FDA endpoint BMD

H.C. Wainwright reiterates Buy rating on Entera Bio stock as FDA qualifies BMD endpoint

L’analogo orale di PTH di Entera Bio mostra una risposta sostenuta del calcio

Entera Bio’s oral PTH analog shows sustained calcium response